Literature DB >> 34040018

Subclinical hypothyroidism or isolated high TSH in hospitalized patients with chronic heart-failure and chronic renal-failure.

Amir Bashkin1,2, Wagde Abu Saleh3, Mona Shehadeh4, Lea Even5,6, Ohad Ronen7,6.   

Abstract

Sub-clinical hypothyroidism (SCH) is common in heart failure (HF) and advanced renal failure (RF), but it is unclear whether there is a thyroid disease or a transient increase in TSH level. This is a retrospective study of hospitalized patients in medical departments. All patients with SCH and a TSH level up to less than 12 mIU/L were identified. Those who had at least one recurring admission within at least 6 months were included. A change in thyroid function during the last re-admission was determined and classified as an improvement, no change, or worsening of thyroid function. Overall, 126 cases of SCH met the inclusion criteria for re-admission. Analysis of the most recent hospitalization showed that in 100 (79.4%) patients thyroid function improved, in 15 (11.9%) patients thyroid function remained unchanged and only in 11 (8.7%) patients did thyroid function worsen. In most cases, worsening of hypothyroidism was determined by initiation of a low dose levothyroxine treatment. Of the 126 participants, 43 (34.1%) and 22 (17.5%) had a diagnosis of HF and RF (CKD stages 4 and 5), respectively. There was no association between HF or advanced RF and worsening of SCH. No association was found between worsening of hypothyroidism and gender, age, TSH, or creatinine levels in the first hospitalization. A borderline association between elevated CRP levels at first hospitalization and hypothyroidism worsening was found (p = 0.066). Mildly elevated TSH in hospitalized patients with HF and advanced RF is transient and most probably not related to thyroid disease and not associated with age or gender.

Entities:  

Year:  2021        PMID: 34040018     DOI: 10.1038/s41598-021-90193-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  3 in total

1.  Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness.

Authors:  G Van den Berghe; P Wouters; F Weekers; S Mohan; R C Baxter; J D Veldhuis; C Y Bowers; R Bouillon
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

2.  The significance of high thyroxine in hospitalized patients with low thyroid-stimulating hormone.

Authors:  Amir Bashkin; Jalaa Abu Ali; Mona Shehadeh; Lea Even; Ohad Ronen
Journal:  Endocrine       Date:  2020-09-02       Impact factor: 3.633

3.  Variation analysis of anti-Müllerian hormone gene in Chinese women with polycystic ovary syndrome.

Authors:  Lang Qin; Shigang Zhao; Ping Yang; Yongzhi Cao; Jiangtao Zhang; Zi-Jiang Chen; Andrea Dunaif; Han Zhao
Journal:  Endocrine       Date:  2020-11-09       Impact factor: 3.633

  3 in total
  1 in total

1.  Independent Association of Thyroid Dysfunction and Inflammation Predicts Adverse Events in Patients with Heart Failure via Promoting Cell Death.

Authors:  Yimin Shen; Guanzhong Chen; Sheng'an Su; Chenchen Zhao; Hong Ma; Meixiang Xiang
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.